510(k) K944604

CX AMPHETAMINES REAGENT FOR SYNCHRON CX SYSTEMS by Beckman-Diagnostic Systems Group — Product Code DKZ

K944604 is an FDA 510(k) premarket notification submitted by Beckman-Diagnostic Systems Group for the device "CX AMPHETAMINES REAGENT FOR SYNCHRON CX SYSTEMS". The FDA issued a decision of Substantially Equivalent on Dec 7, 1994. The device falls under product code DKZ (Enzyme Immunoassay, Amphetamine), a Class II device regulated under 21 CFR 862.3100. Beckman-Diagnostic Systems Group has 10 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 7, 1994
Date Received
Sep 19, 1994
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Enzyme Immunoassay, Amphetamine
Device Class
Class II
Regulation Number
862.3100
Review Panel
TX
Submission Type
510(k)

Need the full FDA record for Beckman-Diagnostic Systems Group? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K944604. Report a data issue: hello@regdatalab.com.